Search Results - "Farraye, Francis"

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study.

Authors: Itzkowitz, Steven Farraye, Francis A Limburg, Paul J et al.

Source: Journal of Crohn's & Colitis. Sep2023, Vol. 17 Issue 9, p1436-1444. 9p.

Patients with Crohn's Disease and Ileostomy Can Respond to Upadacitinib.

Authors: Loeb, Lauren Farraye, Francis A. Crosby, Sheena et al.

Source: Digestive Diseases & Sciences. Sep2025, Vol. 70 Issue 9, p3120-3125. 6p.

ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease.

Authors: Farraye, Francis A. Melmed, Gil Y. Lichtenstein, Gary R. et al.

Source: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Jul2025, Vol. 120 Issue 7, p1447-1473. 27p.

COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.

Authors: Duly, Kristine Farraye, Francis A Bhat, Shubha

Source: American Journal of Health-System Pharmacy. 1/15/2022, Vol. 79 Issue 2, p63-71. 9p. 1 Chart.

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.

Authors: Farraye, Francis A. Qazi, Taha Kotze, Paulo G. et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2021, Vol. 54 Issue 4, p429-440. 12p. 4 Charts, 4 Graphs.

Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.

Authors: Sullivan, Keith M. Farraye, Francis A. Winthrop, Kevin L. et al.

Source: Vaccine. Jan2023, Vol. 41 Issue 1, p36-48. 13p.

Research Communication: Comparative Effectiveness of Ustekinumab and Vedolizumab in the Management of Chronic Pouchitis—A Population‐Based Study.

Authors: Alsakarneh, Saqr Tome, June Farraye, Francis A. et al.

Source: Alimentary Pharmacology & Therapeutics. Feb2026, Vol. 63 Issue 3, p424-428. 5p.

A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study.

Authors: Anastassopoulos, Kathryn Farraye, Francis Knight, Tyler et al.

Source: Digestive Diseases & Sciences. Oct2016, Vol. 61 Issue 10, p2993-3006. 14p.

Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors: Reich, Jason Farraye, Francis Wasan, Sharmeel et al.

Source: Digestive Diseases & Sciences. Aug2016, Vol. 61 Issue 8, p2205-2216. 12p.

Gaps in the diagnosis of small bowel adenocarcinoma among patients with Crohn's disease: a tertiary care perspective.

Authors: Zayat, Marisa-Nicole S. Vander Griend, Micah Hashash, Jana G. et al.

Source: Annals of Gastroenterology. 2026, Vol. 39 Issue 2, p238-246. 9p.

Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection.

Authors: Motwani, Kiran K Hashash, Jana G Farraye, Francis A et al.

Source: Journal of Crohn's & Colitis. Oct2023, Vol. 17 Issue 10, p1681-1688. 8p.

Efficacy of biologic and small molecule agents as second‐line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity‐matched cohort study.

Authors: Kochhar, Gursimran S. Desai, Aakash Farraye, Francis A. et al.

Source: Alimentary Pharmacology & Therapeutics. Aug2023, Vol. 58 Issue 3, p297-308. 12p. 1 Diagram, 3 Charts, 4 Graphs.

Low Incidence of Varicella in Pediatric Patients With Inflammatory Bowel Disease.

Authors: Caldera, Freddy Hayney, Mary S. Farraye, Francis A. et al.

Source: American Journal of Gastroenterology (Lippincott Williams & Wilkins). Sep2025, Vol. 120 Issue 9, p2194-2197. 4p.

Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Acute Pouchitis: A Matched Cohort Study from the United States.

Authors: Alsakarneh, Saqr Camilleri, Michael Farraye, Francis A. et al.

Source: Digestive Diseases & Sciences. Aug2025, Vol. 70 Issue 8, p2760-2767. 8p.

Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease.

Authors: Okafor, Philip Farraye, Francis Okafor, Adetoro et al.

Source: Digestive Diseases & Sciences. Dec2015, Vol. 60 Issue 12, p3743-3755. 13p.

Inadvertent live vaccine administration in adult patients with inflammatory bowel disease on immunosuppressive therapy.

Authors: Ramirez, Oscar Ramirez Farraye, Francis A. Hayney, Mary S. et al.

Source: Vaccine. Dec2024, Vol. 42 Issue 26, pN.PAG-N.PAG. 1p.

MUC1 as a biomarker in primary sclerosing cholangitis and cholangiocarcinoma.

Authors: Hashash, Jana G. Beatty, Pamela Yan, Irene K. et al.

Source: Annals of Gastroenterology. 2026, Vol. 39 Issue 1, p48-53. 6p.

Bezlotoxumab for prevention of Clostridioides difficile recurrence in patients with inflammatory bowel disease: a retrospective multicenter experience.

Authors: Karime, Christian Odah, Tarek Hashash, Jana G. et al.

Source: Annals of Gastroenterology. 2026, Vol. 39 Issue 1, p114-122. 9p.

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists.

Authors: Susiriwatananont, Thiti Eiamprapaporn, Panuch Vazquez Roque, Maria et al.

Source: Cells (2073-4409). Nov2025, Vol. 14 Issue 22, p1779. 26p.

Epidemiology of metabolic syndrome in patients with inflammatory bowel disease: a population-level cohort study from the United States.

Authors: Desai, Aakash Khataniar, Himsikhar Hashash, Jana G. et al.

Source: Annals of Gastroenterology. 2025, Vol. 38 Issue 6, p618-628. 17p.